Dextenza in Pterygium Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 1, 2020

Primary Completion Date

August 5, 2021

Study Completion Date

August 5, 2021

Conditions
Pterygium
Interventions
DRUG

Dexamethasone Intracanalicular Insert, 0.4mg

To determine post-surgical resolution of pain and inflammation outcomes with DEXTENZA compared to topical steroid treatment in patients who undergo pterygium surgery.

DRUG

Prednisolone Acetate 1%

To reduce post-surgical pain and inflammation in patients who undergo pterygium surgery.

Trial Locations (1)

10016

New York Eye Specialists, New York

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Ocular Therapeutix, Inc.

INDUSTRY

lead

Michelle Rhee MD

OTHER

NCT04403516 - Dextenza in Pterygium Surgery | Biotech Hunter | Biotech Hunter